ArticleFrontiers in human neuroscience2026
Long-term use of tDCS-clinical and ethical considerations.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation technique that delivers weak electrical currents to targeted brain regions in order to modulate neural activity and potentially enhance cognitive and motor functions. Clinical studies have reported benefits for conditions such as depression, stroke, and Parkinson's disease, typically with only minor and transient side effects. While short-term safety is relatively well established, the long-term effects require more systematic data and therefore require caution. At the same time, tDCS is increasingly being used at home without supervision for extended periods, as devices can be purchased online without prescription or even self-assembled. This situation highlights the need for appropriate safeguards to protect unsupervised users and to ensure that research into supervised long-term use is conducted under ethically acceptable conditions. In this paper, we specifically assess the risks that may arise from prolonged and unsupervised application of tDCS and propose measures that should be implemented by researchers, regulators, and commercial stakeholders involved in the distribution of tDCS devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.